Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells

被引:10
|
作者
Sasu, Barbra J. [1 ]
Opiteck, Gregory J. [1 ]
Gopalakrishnan, Suhasni [1 ]
Kaimal, Vivek [1 ]
Furmanak, Tom [1 ]
Huang, David [1 ]
Goswami, Angshumala [1 ]
He, Ying [1 ]
Chen, Jiamin [1 ]
Nguyen, Anh [1 ]
Balakumaran, Arun [1 ]
Shah, Nirav N. [2 ]
Hamadani, Mehdi [2 ]
Bone, Kathleen M. [3 ]
Prashad, Sacha [1 ]
Bowen, Michael A. [1 ]
Pertel, Thomas [1 ]
Embree, Heather D. [1 ]
Gidwani, Shalini G. [1 ]
Chang, David [1 ]
Moore, Alison [1 ]
Leonard, Mark [1 ]
Amado, Rafael G. [1 ]
机构
[1] Allogene Therapeut, San Francisco, CA 94080 USA
[2] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA
关键词
INVERSION; IMMUNOGLOBULIN; RECOMBINATION; IMMUNOTHERAPY; LYMPHOCYTES; INTEGRATION; ALIGNMENT; LYMPHOMA; THERAPY; SITES;
D O I
10.1016/j.ymthe.2022.12.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A chromosome 14 inversion was found in a patient who devel-oped bone marrow aplasia following treatment with allogeneic chimeric antigen receptor (CAR) Tcells containing gene edits made with transcription activator-like effector nucleases (TALEN). TALEN editing sites were not involved at either breakpoint. Recombination signal sequences (RSSs) were found suggesting recombination-activating gene (RAG) -medi-ated activity. The inversion represented a dominant clone de-tected in the context of decreasing absolute CAR Tcell and overall lymphocyte counts. The inversion was not associated with clinical consequences and wasnot detected in the drug product administered to this patient or in any drug product used in this or other trials using the same manufacturing pro-cesses. Neither was the inversion detected in this patient at earlier time points or in any other patient enrolled in this or other trials treated with this or other product lots. This case il-lustrates that spontaneous, possibly RAG-mediated, recombi-nation events unrelated to gene editing can occur in adoptive cell therapy studies, emphasizes the need for ruling out off -target gene editing sites, and illustrates that other processes, such as spontaneous V(D)J recombination, can lead to chromo-somal alterations in infused cells independent of gene editing.
引用
收藏
页码:676 / 685
页数:10
相关论文
共 50 条
  • [31] A NOVEL GENE-EDITED REGULATORY T CELL PRODUCT RESISTANT TO TACROLIMUS
    Zarrinrad, G.
    Wendering, D.
    Schlickeiser, S.
    Peter, L.
    Schulenberg, S.
    Picht, S.
    Wagner, D.
    Ou, K.
    Polansky-Biskup, J.
    Mashreghi, M. F.
    Volk, H. D.
    Reinke, P.
    Schmueck-Henneresse, M.
    Amini, L.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A37 - A38
  • [32] A Novel Quantification Method for Gene-Edited Animal Detection Based on ddPCR
    Wang, Kaili
    Ji, Yi
    Peng, Cheng
    Wang, Xiaofu
    Yang, Lei
    Lan, Hangzhen
    Xu, Junfeng
    Chen, Xiaoyun
    BIOLOGY-BASEL, 2025, 14 (02):
  • [33] Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
    Graham, Charlotte Elizabeth
    Jozwik, Agnieszka
    Quartey-Papafio, Ruby
    Ioannou, Nikolaos
    Metelo, Ana M.
    Scala, Carlo
    Dickson, Glenda
    Stewart, Orla
    Almena-Carrasco, Maria
    Peranzoni, Elisa
    Ramsay, Alan G.
    Patten, Piers E. M.
    Pertel, Thomas
    Farzaneh, Farzin
    Dupouy, Sandra
    Pepper, Andrea
    Benjamin, Reuben
    LEUKEMIA, 2021, 35 (12) : 3581 - 3584
  • [34] Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
    Charlotte Elizabeth Graham
    Agnieszka Jozwik
    Ruby Quartey-Papafio
    Nikolaos Ioannou
    Ana M. Metelo
    Carlo Scala
    Glenda Dickson
    Orla Stewart
    Maria Almena-Carrasco
    Elisa Peranzoni
    Alan G. Ramsay
    Piers E. M. Patten
    Thomas Pertel
    Farzin Farzaneh
    Sandra Dupouy
    Andrea Pepper
    Reuben Benjamin
    Leukemia, 2021, 35 : 3581 - 3584
  • [35] Qualitative and Quantitative Detection of CRISPR-Associated Cas Gene in Gene-Edited Foods
    Ding, Lin
    Xu, Xiaoli
    Wang, Xiaofu
    Chen, Xiaoyun
    Lu, Yuwen
    Xu, Junfeng
    Peng, Cheng
    FOODS, 2023, 12 (19)
  • [36] GENE-EDITED CHICKEN CELLS RESIST BIRD FLU VIRUS IN THE LAB
    不详
    VETERINARY RECORD, 2019, 184 (23) : 698 - 698
  • [37] EU proposal on gene-edited crops doesn't go far enough
    Mehta, Devang
    NATURE, 2023, 619 (7970) : 437 - 437
  • [38] Rescue of T-cell deficiency in PRKDC SCID mice by transplantation of gene-edited haematopoietic stem cells
    Rocca, C.
    Abdul-Razak, H. H.
    Howe, S. J.
    Alonso-Ferrero, M. Eugenia
    Gabriel, R.
    Bartholomae, C. C.
    Gan, C. H. Victor
    Garin, M.
    Molina Estevez, F. Javier
    Roberts, A.
    Blundell, M.
    Wang, J.
    Prakash, V.
    Gueenechea, G.
    Holmes, M. C.
    Gregory, P. D.
    Kinnon, C.
    von Kalle, C.
    Schmidt, M.
    Antonio Bueren, J.
    Thrasher, A. J.
    Yanez-Munoz, R. J.
    HUMAN GENE THERAPY, 2013, 24 (12) : A52 - A53
  • [39] Enabling Gene-Edited, Regulatory-like, T Cells (edTreg) for Treatment of IPEX and Other Autoimmune Disorders
    Honaker, Yuchi
    Sommer, Karen
    Dahl, Noelle
    Xiang, Yufei
    Lopez, Christina
    Scharffenberger, Samuel
    Christian, Michelle
    Torgerson, Troy R.
    Scharenberg, Andrew M.
    Rawlings, David J.
    BLOOD, 2019, 134
  • [40] Targeting T cell malignancies with gene edited CAR-T
    Dipersio, John F.
    Cooper, Matthew
    CANCER RESEARCH, 2018, 78 (13)